The European Journal of Health Economics
2002 - 2025
Current editor(s): J.-M.G.v.d. Schulenburg From: Springer Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC. Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing (). Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.
Volume 26, issue 1, 2025
- Obesity epidemic in European countries: from an unaddressed risk factor to a medicalized disease? pp. 1-5

- Livio Garattini and Giovanni Fattore
- The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events pp. 7-21

- Cate Bailey, Kim Dalziel, Leanne Constable, Nancy J. Devlin, Harriet Hiscock, Helen Skouteris and Tessa Peasgood
- Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial pp. 23-34

- Ansam Barakat, Jurgen E. Cornelis, Jack J. M. Dekker, Nick M. Lommerse, Aartjan T. F. Beekman and Matthijs Blankers
- Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden pp. 35-48

- Thomas Sejersen, Sophie Graham, Anne-Berit Ekström, Anna-Karin Kroksmark, Marta Kwiatkowska, Michael L. Ganz, Nahila Justo, Karl Gertow and Alex Simpson
- Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system pp. 49-62

- Silvia Fenix-Caballero, Adrián Sanchez-Vegas, Emilio Jesús Alegre Del-Rey, David Epstein, Leticia Garcia-Mochon and Antonio Olry de Labry Lima
- Mapping functions for the PHQ-9 and GAD-7 to generate EQ-5D-3L for economic evaluation pp. 63-70

- Clara Mukuria, Matthew Franklin and Sebastian Hinde
- The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries pp. 71-85

- Hamraz Mokri, Pieter Baal and Maureen Rutten- van Mölken
- Is there a link between health care utilisation and subjective well-being? An exploratory study among older Danes pp. 87-93

- Maiken Skovrider Aaskoven, Trine Kjær and Dorte Gyrd-Hansen
- Do institutions matter for citizens’ health status? Empirical evidence from Italy pp. 95-115

- M. Alessandra Antonelli and Giorgia Marini
- Costs associated with insufficient physical activity in Germany: cross-sectional results from the baseline examination of the German national cohort (NAKO) pp. 117-128

- Sophie Gottschalk, Hans-Helmut König, Andrea Weber, Michael F. Leitzmann, Michael J. Stein, Annette Peters, Claudia Flexeder, Lilian Krist, Stefan N. Willich, Katharina Nimptsch, Tobias Pischon, Sylvia Gastell, Karen Steindorf, Florian Herbolsheimer, Nina Ebert, Karin B. Michels, Anja Dorrn, Volker Harth, Nadia Obi, André Karch, Henning Teismann, Henry Völzke, Claudia Meinke-Franze, Leon Klimeck, Teresa L. Seum and Judith Dams
- Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care pp. 129-139

- Giulio Cisco, Armando N. Meier, Nicolas Senn, Yolanda Mueller, Andreas Kronenberg, Isabella Locatelli, José Knüsli, Loïc Lhopitallier, Noemie Boillat-Blanco and Joachim Marti
- Letter to the Editor: Lazzaro responds to Kennedy et al pp. 141-142

- Carlo Lazzaro
- Correction: AOTMiT reimbursement recommendations compared to other HTA agencies pp. 143-146

- Aneta Mela, Dorota Lis, Elżbieta Rdzanek, Janusz Jaroszyński, Marzena Furtak-Niczyporuk, Bartłomiej Drop, Tomasz Blicharski and Maciej Niewada
Volume 25, issue 9, 2024
- Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China pp. 1471-1484

- Aixue Zhang, Jing Li, Zhuxin Mao, Zitong Wang, Jing Wu, Nan Luo, Peng Liu and Pei Wang
- What remains after the money ends? Evidence on whether admission reductions continued following the largest health and social care integration programme in England pp. 1485-1504

- Vasudha Wattal, Katherine Checkland, Matt Sutton and Marcello Morciano
- Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease pp. 1505-1515

- Richard Huan Xu, Nan Luo and Dong Dong
- The causal effect of early retirement on medication use across sex and occupation: evidence from Danish administrative data pp. 1517-1527

- Jolien Cremers, Torben Heien Nielsen and Claus Thorn Ekstrøm
- Cost awareness among intensivists in their daily clinical practice: a prospective multicentre study pp. 1529-1537

- Timothée Lehut, Céline Lambert, Romain Mortier, Emmanuel Futier, Russell Chabanne, Ulrich Bauer, Philippe Verdier, Ramin Ravan, Philippe Ocquidant, Charline Mourgues and Alexandre Lautrette
- The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands pp. 1539-1555

- Micha J. Pilz, Simon Seyringer, Lára R. Hallsson, Andrew Bottomley, Femke Jansen, Madeleine T. King, Richard Norman, Marianne J. Rutten, Irma M. Verdonck- de Leeuw, Peter D. Siersema and Eva Maria Gamper
- Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands pp. 1557-1567

- Simon Pol, Maarten J. Postma and Cornelis Boersma
- Economic value of diastasis repair with the use of mesh compared to no intervention in Italy pp. 1569-1580

- Carla Rognoni, Alessandro Carrara, Micaela Piccoli, Vincenzo Trapani, Nereo Vettoretto, Giorgio Soliani and Rosanna Tarricone
- From test to rest: evaluating socioeconomic differences along the COVID-19 care pathway in the Netherlands pp. 1581-1594

- Iris Meulman, Ellen Uiters, Mariëlle Cloin, Jeroen Struijs, Johan Polder and Niek Stadhouders
- Costs attributable to hypercholesterolemia in a single period and over the life cycle pp. 1595-1603

- Stephanie Reitzinger, Miriam Reiss and Thomas Czypionka
- Poverty, work intensity, and disability: evidence from European countries pp. 1605-1624

- Chiara Mussida and Dario Sciulli
- Comparing GPs according to their model of practice: are multiprofessional group practices associated with more favourable working conditions? pp. 1625-1640

- Myriam Biais, Matthieu Cassou and Carine Franc
Volume 25, issue 8, 2024
- AOTMiT reimbursement recommendations compared to other HTA agencies pp. 1291-1310

- Aneta Mela, Dorota Lis, Elżbieta Rdzanek, Janusz Jaroszyński, Marzena Furtak-Niczyporuk, Bartłomiej Drop, Tomasz Blicharski and Maciej Niewada
- The Economic Costs of Informal Care: Estimates from a National Cross-Sectional Survey in The Netherlands pp. 1311-1331

- Saif Elayan, Viola Angelini, Erik Buskens and Alice Boer
- A Spanish value set for the SF-6D based on the SF-12 v1 pp. 1333-1343

- Jorge-Eduardo Martínez-Pérez, José-María Abellán-Perpiñán, Fernando-Ignacio Sánchez-Martínez and Juan-José Ruiz-López
- Comparing heuristic valuation processes between health state valuation from child and adult perspectives pp. 1345-1360

- Stefan A. Lipman and Vivian T. Reckers-Droog
- Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers pp. 1361-1370

- Wenjing Zhou, Anle Shen, Zhihao Yang, Pei Wang, Bin Wu, Michael Herdman, Jan Busschbach and Nan Luo
- Unravelling risk selection in Spanish general government employee mutual funds: evidence from cancer hospitalizations in the public health network pp. 1371-1381

- Jaime Pinilla, Beatriz G. López-Valcárcel and Enrique Bernal-Delgado
- Measuring EQ-5D-5L utility values in parents who have experienced perinatal death pp. 1383-1391

- Elizabeth M. Camacho, Katherine J. Gold, Margaret Murphy, Claire Storey and Alexander E. P. Heazell
- A principled approach to non-discrimination in cost-effectiveness pp. 1393-1416

- Darius Lakdawalla and Jason N. Doctor
- Systematic methodological review of health state values in glaucoma cost-utility analyses pp. 1417-1435

- Kevin Kennedy, Gurkaran Sarohia, Dominik Podbielski, Simon Pickard, Jean-Eric Tarride and Feng Xie
- Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD) pp. 1437-1448

- Louis S. Matza, Katie D. Stewart, Marie Fournier, Donna Rowen, Robin Lachmann, Maurizio Scarpa, Eugen Mengel, Travis Obermeyer, Evren Ayik, Fernando Laredo and Ruth Pulikottil-Jacob
- The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands pp. 1449-1459

- Vivian Reckers-Droog, Joost Enzing and Werner Brouwer
- Preference-based utility weights for the Individualized Neuromuscular Quality of Life Questionnaire (INQoL), with a focus on non-dystrophic myotonia (NDM) pp. 1461-1469

- Andrew Lloyd, Kim Rand, Cleo Pike and Crispin Ellis
Volume 25, issue 7, 2024
- Exploring non-iterative time trade-off methods for valuation of EQ-5D-5L health states pp. 1087-1094

- Zhihao Yang, Kim Rand, Elly Stolk, Jan Busschbach and Nan Luo
- Impact of Long COVID on productivity and informal caregiving pp. 1095-1115

- Joseph Kwon, Ruairidh Milne, Clare Rayner, Román Rocha Lawrence, Jordan Mullard, Ghazala Mir, Brendan Delaney, Manoj Sivan and Stavros Petrou
- Risk adjustment for regional healthcare funding allocations with ensemble methods: an empirical study and interpretation pp. 1117-1131

- Tuukka Holster, Shaoxiong Ji and Pekka Marttinen
- Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK pp. 1133-1146

- J. P. Sevilla, Daniel Tortorice, David Kantor, John Regan, Kinga H. Meszaros, Ekkehard C. Beck, Najida Begum and David E. Bloom
- The impact of an ‘evergreening’ strategy nearing patent expiration on the uptake of biosimilars and public healthcare costs: a case study on the introduction of a second administration form of trastuzumab in The Netherlands pp. 1147-1163

- Ghyli Kirshner, Peter Makai, Chiara Brouns, Lonneke Timmers and Ron Kemp
- Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people pp. 1165-1176

- Tracey H. Sach, Mary Onoja, Holly Clarke, Miriam Santer, Ingrid Muller, Taeko Becque, Beth Stuart, Julie Hooper, Mary Steele, Sylvia Wilczynska, Matthew J. Ridd, Amanda Roberts, Amina Ahmed, Lucy Yardley, Paul Little, Kate Greenwell, Katy Sivyer, Jacqui Nuttall, Gareth Griffiths, Sandra Lawton, Sinéad M. Langan, Laura Howells, Paul Leighton, Hywel C. Williams and Kim S. Thomas
- Looking inside the lab: a systematic literature review of economic experiments in health service provision pp. 1177-1204

- Massimo Finocchiaro Castro, Calogero Guccio and Domenica Romeo
- A state-level analysis of macro-level factors associated with hospital readmissions pp. 1205-1215

- Reginald A. Silver, Joumana Haidar and Chandrika Johnson
- Can redistribution of vaccine improve global welfare? Lessons from COVID-19 pp. 1217-1238

- Gunjan Kumari and Oindrila Dey
- On spillovers in economic evaluations: definition, mapping review and research agenda pp. 1239-1260

- María J. Mendoza-Jiménez, Job Exel and Werner Brouwer
- Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis pp. 1261-1273

- Andrea Marcellusi, Francesco Saverio Mennini, Massimo Andreoni and Loreta A. Kondili
- Pragmatic randomized controlled trial comparing a complex telemedicine-based intervention with usual care in patients with chronic conditions pp. 1275-1289

- Susanna Sten-Gahmberg, Kine Pedersen, Ingrid Gaarder Harsheim, Hanna Isabel Løyland, Øyvind Snilsberg, Tor Iversen, Geir Godager, Erik Magnus Sæther and Birgit Abelsen
Volume 25, issue 6, 2024
- Valuation of EQ-5D-5L health states from cancer patients’ perspective: a feasibility study pp. 915-924

- Qingqing Chai, Zhihao Yang, Xiaoyan Liu, Di An, Jiangyang Du, Xiumei Ma, Kim Rand, Bin Wu and Nan Luo
- The economic burden of mental disorders: results from the Netherlands mental health survey and incidence study-2 pp. 925-934

- B. F. M. Wijnen, M. Have, R. Graaf, H. J. Hoek, J. Lokkerbol and Filip Smit
- How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe pp. 935-950

- Anna-Maria Fontrier, Bregtje Kamphuis and Panos Kanavos
- New evidence on supplier-induced demand in China’s public tertiary hospitals: is the cost of hospitalization higher in the off-season? pp. 951-962

- Chi Shen, Qiwei Deng, Sha Lai, Liu Yang, Dantong Zhao, Yaxin Zhao and Zhongliang Zhou
- Healthcare information management and operational cost performance: empirical evidence pp. 963-977

- Amit S. Malhan, Kiarash Sadeghi-R, Robert Pavur and Lou Pelton
- Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy pp. 979-997

- Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers, Tobias Boch and Julia Caroline Michaeli
- Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders pp. 999-1011

- Mario Cesare Nurchis, Francesca Clementina Radio, Luca Salmasi, Aurora Heidar Alizadeh, Gian Marco Raspolini, Gerardo Altamura, Marco Tartaglia, Bruno Dallapiccola and Gianfranco Damiani
- Country-level effects of diagnosis-related groups: evidence from Germany’s comprehensive reform of hospital payments pp. 1013-1030

- Robert Messerle and Jonas Schreyögg
- Patient-reported experience is associated with higher future revenue and lower costs of hospitals pp. 1031-1039

- Alice Giese, Rasheda Khanam, Son Nghiem, Thomas Rosemann and Michael M. Havranek
- Beyond 10-year lead-times in EQ-5D-5L: leveraging alternative lead-times in willingness-to-accept questions to capture preferences for worse-than-dead states and their implication pp. 1041-1055

- Jen-Yu Amy Chang, Chien-Ning Hsu, Juan Manuel Ramos-Goñi, Nan Luo, Hsiang-Wen Lin and Fang-Ju Lin
- Projected costs of informal care for older people in England pp. 1057-1070

- Bo Hu, Javiera Cartagena-Farias, Nicola Brimblecombe, Shari Jadoolal and Raphael Wittenberg
- The elicitation of patient and physician preferences for calculating consumer-based composite measures on hospital report cards: results of two discrete choice experiments pp. 1071-1085

- Martin Emmert, Stefan Rohrbacher, Florian Meier, Laura Heppe, Cordula Drach, Anja Schindler, Uwe Sander, Christiane Patzelt, Cornelia Frömke, Oliver Schöffski and Michael Lauerer
Volume 25, issue 5, 2024
- Length of hospital stays and financial incentives: evidence from Dutch rehabilitation centers pp. 731-741

- Katalin Gaspar, Ramsis Croes, Misja Mikkers and Xander Koolman
- The impacts of working from home on individual health and well-being pp. 743-762

- Manuel Denzer and Philipp Grunau
- Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis pp. 763-774

- Lorna Wills, Diana Nagarwalla, Clare Pearson, Sean McPhail, Rose Hinchliffe, Ben Sharpless, Fahmina Fardus-Reid, Lyndsy Ambler, Samantha Harrison and Jon Shelton
- Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancer pp. 775-785

- Szu-Chun Yang, Wu-Wei Lai, Tzu-I. Wu, Jing-Shiang Hwang, Jung- Der Wang and Fuhmei Wang
- Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec pp. 787-811

- Christian R. C. Kouakou, Jie He and Thomas G. Poder
- How do family doctors respond to reduced waiting times for cancer diagnosis in secondary care? pp. 813-828

- Helen Hayes, Rachel Meacock, Jonathan Stokes and Matt Sutton
- A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe pp. 829-844

- Li Sun, Shruti Patel, Camilla Fiorina, Audrey Glass, Lise Rochaix, Anna M. Foss and Rosa Legood
- Assessing the relation between financial performance and long-term bank loan interest rates for healthcare providers in the Netherlands: a panel data analysis pp. 845-855

- Erik Wackers, Rick Smit, Niek Stadhouders and Patrick Jeurissen
- Pay-for-Performance incentives for specialised services in England: a mixed methods evaluation pp. 857-876

- Yan Feng, Søren Rud Kristensen, Paula Lorgelly, Rachel Meacock, Alberto Núñez, Marina Rodés-Sánchez, Luigi Siciliani and Matt Sutton
- Shaping a suitable EU HTA dossier template: why the German template is not fit for purpose pp. 877-888

- Maria Katharina Schweitzer, Manuel Nico Dold, Astrid Genet, Klaus Gossens, Thomas Klein-Hessling, Nils Löffler, Matthias Rabel, Andrej Rasch, Eva-Maria Reuter, Jessica Schmelcher, Natalia Wolfram and Sebastian Werner
- The EORTC QLU-C10D: the Hong Kong valuation study pp. 889-901

- Richard Huan Xu, Eliza Lai-yi Wong, Nan Luo, Richard Norman, Jens Lehmann, Bernhard Holzner, Madeleine T. King and Georg Kemmler
- Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice experiment pp. 903-913

- Saskia Schawo, Renske Hoefman, Vivian Reckers-Droog, Liesbet Lawerman- van de Wetering, Yifrah Kaminer, Werner Brouwer and Leona Hakkaart- van Roijen
Volume 25, issue 4, 2024
- Psychometric properties and general population reference values for PROMIS Global Health in Hungary pp. 549-562

- Alex Bató, Valentin Brodszky, Ariel Zoltán Mitev, Balázs Jenei and Fanni Rencz
- Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic pp. 563-578

- Sebastian Himmler, Job Exel, Werner Brouwer, Sebastian Neumann-Böhme, Iryna Sabat, Jonas Schreyögg, Tom Stargardt, Pedro Barros and Aleksandra Torbica
- Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study pp. 579-600

- Vivienne Hillerich, Frederik Valbert, Silke Neusser, Oliver Pfaar, Ludger Klimek, Annette Sperl, Thomas Werfel, Eckard Hamelmann, Cordula Riederer, Stefanie Wobbe-Ribinski, Anja Neumann, Jürgen Wasem and Janine Biermann-Stallwitz
- The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off pp. 601-613

- Zhongyu Lang, Arthur Attema and Stefan A. Lipman
- The effect of telephone health coaching and remote exercise monitoring for peripheral artery disease (TeGeCoach) on health care cost and utilization: results of a randomized controlled trial pp. 615-629

- Dirk Heider, Farhad Rezvani, Herbert Matschinger, Jörg Dirmaier, Martin Härter, Lutz Herbarth, Patrick Steinisch, Hannes Böbinger, Franziska Schuhmann, Gundula Krack, Thomas Korth, Lara Thomsen, Daniela Patricia Chase, Robert Schreiber, Mark-Dominik Alscher, Benjamin Finger and Hans-Helmut König
- Factors associated with the author-reported cost-effectiveness threshold in high-income countries: systematic review and multivariable modelling pp. 631-639

- Nicolas Boespflug, Jérôme Wittwer and Antoine Bénard
- Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma pp. 641-653

- Jean-Baptiste Trouiller, Georgios F. Nikolaidis, Bérengère Macabeo, Nicolas Meyer, Laetitia Gerlier, Max Schlueter and Philippe Laramee
- Scales and size-quality outcomes in adult learning disability residential care: evidence from the UK pp. 655-669

- Chelsea Chunwen Xiao, Nikita Makarchev and Xin Tao
- Disclosing the ‘Big C’: what does cancer survivorship signal to employers? pp. 671-688

- Philippe Sterkens, Adelina Sharipova and Stijn Baert
- Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland pp. 689-699

- Jeroen H. J. Paulissen, Ahmed H. Seddik, Kyle J. Dunton, Christopher J. Livings, Marinus Hulst, Maarten J. Postma, Lisa A. Jong and Roel D. Freriks
- Immigrant assimilation in health care utilisation in Spain pp. 701-715

- Zuleika Ferre, Patricia Triunfo and José Ignacio Antón
- Using machine learning to estimate health spillover effects pp. 717-730

- Bruno Wichmann and Roberta Moreira Wichmann
Volume 25, issue 3, 2024
- Primary care services and emergency department visits in blended fee-for-service and blended capitation models: evidence from Ontario, Canada pp. 363-377

- Michael Hong, Rose Anne Devlin, Gregory S. Zaric, Amardeep Thind and Sisira Sarma
- Heteroscedasticity of residual spending after risk equalization: a potential source of selection incentives in health insurance markets with premium regulation pp. 379-396

- Michel Oskam, Richard C. van Kleef and Rudy Douven
- Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis pp. 397-409

- Michael Situ, Ute I. Schwarz, Guangyong Zou, Eric McArthur, Richard B. Kim, Amit X. Garg and Sisira Sarma
- A cost-of-illness study of Behçet syndrome in Italy pp. 411-422

- Valentina Lorenzoni, Diana Marinello, Ilaria Palla, Marta Mosca, Giuseppe Turchetti and Rosaria Talarico
- Self-interest, positional concerns and distributional considerations in healthcare preferences pp. 423-446

- Aemiro Melkamu Daniel, Job Exel and Caspar G. Chorus
- Cost-effectiveness of transcatheter aortic valve implantation in patients at low surgical risk in France: a model-based analysis of the Evolut LR trial pp. 447-457

- Didier Tchétché, Coline Dubois Gennes, Quentin Cormerais, Benjamin P. Geisler, Camille Dutot, Fanny Wilquin-Bequet, Manon Breau-Brunel, Béranger Lueza and Jan B. Pietzsch
- Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan pp. 459-470

- Munenobu Kashiwa
- Analyzing nurses’ decisions to leave their profession—a duration analysis pp. 471-496

- Martin Kroczek
- Informal care at old age at home and in nursing homes: determinants and economic value pp. 497-511

- Quitterie Roquebert and Marianne Tenand
- Excess healthcare expenditure in adults treated for solid cancer in childhood: a cohort study in France pp. 513-523

- Daniel Bejarano-Quisoboni, Henri Panjo, Brice Fresneau, Chiraz El‑Fayech, François Doz, Aurore Surun, Florent Vathaire and Nathalie Pelletier-Fleury
- The link between physician motivation and care pp. 525-537

- Anne Sophie Oxholm, Dorte Gyrd-Hansen, Christian Bøtcher Jacobsen, Ulrich Thy Jensen and Line Bjørnskov Pedersen
- Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease pp. 539-548

- Isa Maria Steiner, Bernd Bokemeyer and Tom Stargardt
Volume 25, issue 2, 2024
- Modeling European health systems: an ideal chain of services pp. 189-192

- Livio Garattini and Marco Badinella Martini
- The causal effect of catastrophic health expenditure on poverty in Poland pp. 193-206

- Aleksandra Kolasa and Ewa Weychert
- Nonprofit behavior altered by monetary donations: evidence from the U.S. hospice industry pp. 207-220

- Miao Guo, Lei Guo and Yang Li
- Pay-for-performance programs effectiveness in healthcare: the case of the end-stage renal disease quality incentive program pp. 221-236

- Saeed Piri
- Alcohol prices, the April effect, and the environment, in violence-related injury in England and Wales pp. 237-255

- Kent Matthews, Saeed Heravi, Peter Morgan, Nicholas Page, Jonathan Shepherd and Vaseekaran Sivarajasingam
- Analysis of oncological drugs authorised in Spain in the last decade: association between clinical benefit and reimbursement pp. 257-267

- P. Nieto-Gómez, C. Castaño-Amores, A. Rodríguez-Delgado and R. Álvarez-Sánchez
- Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort pp. 269-279

- Isabella Vanorio-Vega, Panayotis Constantinou, Victor Bret, Stéphanie Gentile, Patrik Finne, Bénédicte Sautenet, Philippe Tuppin and Cécile Couchoud
- Health impact of borders: general reflections and a case study from the Polish–German border pp. 281-292

- Julia Kuntosch, Marie-Luise Ruebsam, Jakub Orsson, Dorota Orsson, Klaus Hahnenkamp, Jörg Hartleib and Steffen Flessa
- Referring physicians' intention to use hospital report cards for hospital referral purposes in the presence or absence of patient-reported outcomes: a randomized trial pp. 293-305

- Martin Emmert, Anja Schindler, Laura Heppe, Uwe Sander, Christiane Patzelt, Michael Lauerer, Eckhard Nagel, Cornelia Frömke, Oliver Schöffski and Cordula Drach
- Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma pp. 307-317

- Béranger Lueza, Anne Aupérin, Charlotte Rigaud, Thomas G. Gross, Marta Pillon, Rafael F. Delgado, Anne Uyttebroeck, G. A. Amos Burke, József Zsíros, Monika Csóka, Mathieu Simonin, Catherine Patte, Véronique Minard-Colin and Julia Bonastre
- Generating EQ-5D-3L health utility scores from the Edinburgh Postnatal Depression Scale: a perinatal mapping study pp. 319-332

- Elizabeth M. Camacho, Gemma E. Shields, Carolyn A. Chew-Graham, Emily Eisner, Simon Gilbody, Elizabeth Littlewood, Dean McMillan, Kylie Watson, Pasco Fearon and Deborah J. Sharp
- Education and medication use later in life and the role of intelligence pp. 333-361

- Gianmaria Niccodemi and Govert Bijwaard
Volume 25, issue 1, 2024
- Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality pp. 1-5

- Maurizio Capuozzo, Venere Celotto, Andrea Zovi, Roberto Langella and Francesco Ferrara
- Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population pp. 7-19

- Shitong Xie, Jing Wu and Gang Chen
- Health-related quality of life assessed by EQ-5D-5L and its determinants among rural adults: result from the Henan rural cohort study pp. 21-30

- Shengxiang Sang, Wei Liao, Ning Kang, Xueyan Wu, Ze Hu, Xiaotian Liu, Hongjian Zhang and Chongjian Wang
- The trade-off between health system resiliency and efficiency: evidence from COVID-19 in European regions pp. 31-47

- Alvaro Almeida
- The role of education in health policy reform outcomes: evidence from Japan pp. 49-76

- Masato Oikawa
- Does a free maternity policy in Kenya work? Impact and cost–benefit consideration based on demographic health survey data pp. 77-89

- Boniface Oyugi, Olena Nizalova, Sally Kendall and Stephen Peckham
- Risk, time preferences, trustworthiness and COVID-19 preventive behavior: evidence from France pp. 91-101

- Julien Bergeot and Florence Jusot
- Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy pp. 103-115

- Richard Huan Xu, Yi Dai, Shamay S. M. Ng, Hector W. H. Tsang, Shuyang Zhang and Dong Dong
- COVID-19 and EQ-5D-5L health state valuation pp. 117-145

- Edward J. D. Webb, Paul Kind, David Meads and Adam Martin
- Canada population norms for the EQ-5D-5L pp. 147-155

- Jiajun Yan, Shitong Xie, Jeffrey A. Johnson, Eleanor Pullenayegum, Arto Ohinmaa, Stirling Bryan and Feng Xie
- Short- and intermediate-term impact of DTC telemedicine consultations on subsequent healthcare consumption pp. 157-176

- Cecilia Dahlgren, Emma Spånberg, Sofia Sveréus, Margareta Dackehag, Per Wändell and Clas Rehnberg
- Cost-effectiveness analysis of (accelerated) pre-operative versus (conventional) post-operative radiotherapy for patients with oral cavity cancer in Sweden pp. 177-185

- Maria Silfverschiöld, Kristin Carlwig, Johan Jarl, Lennart Greiff, Per Nilsson, Johan Wennerberg, Björn Zackrisson, Ellinor Östensson and Johanna Sjövall
- Correction: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic pp. 187-187

- Sebastian Himmler, Job Exel, Werner Brouwer, Sebastian Neumann-Böhme, Iryna Sabat, Jonas Schreyögg, Tom Stargardt, Pedro Barros and Aleksandra Torbica
| |